NEW YORK, Aug. 14, 2023 /PRNewswire/ — Attention Apellis Pharmaceuticals, Inc. (“Apellis”) (NASDAQ: APLS) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between January 28, 2021 and July 28, 2023. If…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.